Lymph node metastases as only qualifier for stage IV serous ovarian cancer confers longer survival than other sites of distant disease - a Swedish Gynecologic Cancer Group (SweGCG) study.

MLA

Hjerpe, Elisabet, et al. “Lymph Node Metastases as Only Qualifier for Stage IV Serous Ovarian Cancer Confers Longer Survival than Other Sites of Distant Disease - a Swedish Gynecologic Cancer Group (SweGCG) Study.” Acta Oncologica (Stockholm, Sweden), vol. 57, no. 3, Mar. 2018, pp. 331–37. EBSCOhost, https://doi.org/10.1080/0284186X.2017.1400691.

APA

Hjerpe, E., Staf, C., Dahm-Kähler, P., Stålberg, K., Bjurberg, M., Holmberg, E., Borgfeldt, C., Tholander, B., Hellman, K., Kjølhede, P., Högberg, T., Rosenberg, P., & Åvall-Lundqvist, E. (2018). Lymph node metastases as only qualifier for stage IV serous ovarian cancer confers longer survival than other sites of distant disease - a Swedish Gynecologic Cancer Group (SweGCG) study. Acta Oncologica (Stockholm, Sweden), 57(3), 331–337. https://doi.org/10.1080/0284186X.2017.1400691

Chicago

Hjerpe, Elisabet, Christian Staf, Pernilla Dahm-Kähler, Karin Stålberg, Maria Bjurberg, Erik Holmberg, Christer Borgfeldt, et al. 2018. “Lymph Node Metastases as Only Qualifier for Stage IV Serous Ovarian Cancer Confers Longer Survival than Other Sites of Distant Disease - a Swedish Gynecologic Cancer Group (SweGCG) Study.” Acta Oncologica (Stockholm, Sweden) 57 (3): 331–37. doi:10.1080/0284186X.2017.1400691.